Across TCGA pan-cancer cohorts, STMN3 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated STMN3 data layer compared with 20 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher STMN3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated STMN3 expression acts as an unfavorable survival marker.

COAD, LGG, and BLCA are the cancer types where STMN3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.045	0.871	<.001	30	view →
LGG	OS	Median	All	0.006	0.896	<.001	12	view →
BLCA	OS	Median	IV	0.153	0.599	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: STMN3 tumor-vs-normal RNA expression · all STMN3 data types